BED BATH & BEYOND, INC. Financials
Quarterly XBRL submissions from SEC 10-K and 10-Q filings.
Income Statement (Last 8 Quarters)
(3)| Period | Revenue | YoY % | Net Income | YoY % | Operating Income | EPS |
|---|---|---|---|---|---|---|
| Q3 FY202510-Q · 2025-09-30 | $257.2M | — | -$4.5M | — | -$12.5M | -$0.07 |
| Q2 FY202510-Q · 2025-06-30 | $282.3M | — | -$19.3M | — | -$17.9M | -$0.34 |
| Q1 FY202510-Q · 2025-03-31 | $231.7M | — | -$39.9M | — | -$23.5M | -$0.74 |
Balance Sheet
| Period | Total Assets | Total Liabilities | Cash & Equivalents | Shareholders Equity |
|---|---|---|---|---|
| Q3 FY202510-Q | $414.4M | $211.4M | $167.4M | $202.6M |
| Q2 FY202510-Q | $358.1M | $226.9M | $120.6M | $130.9M |
| Q1 FY202510-Q | $363.7M | $220.4M | $114.6M | $0 |
Cash Flow Highlights
| Period | Operating Income | Net Income | Gross Profit | Shares Outstanding |
|---|---|---|---|---|
| Q3 FY202510-Q | -$12.5M | -$4.5M | $65.2M | 64,984,000 |
| Q2 FY202510-Q | -$17.9M | -$19.3M | $67.0M | 57,405,000 |
| Q1 FY202510-Q | -$23.5M | -$39.9M | $58.1M | 56,832,000 |
Filings
(4)Methodology
Every figure on this page is pulled directly from BED BATH & BEYOND, INC.'s own XBRL submissions to the U.S. Securities and Exchange Commission. XBRL is the standardized tagging format the SEC requires for line items in 10-K and 10-Q filings, which means revenue, net income, and balance-sheet entries are reported by the company itself — not estimated by us.
Cayman Journal reconciles preferred GAAP tags (for example, Revenues, RevenueFromContractWithCustomerExcludingAssessedTax) and normalizes them so quarter-over-quarter comparability is preserved. Our automated ingestion runs nightly; markets editors spot-check flagged anomalies before they appear on the public hub. Where a tag is missing for a given period, we surface an em dash rather than impute a value.
Source documents are linked under Filings above and point to the original EDGAR submission index. Errors should be reported to [email protected].